levensten law firm logo

FDA Evaluating Link Between Byetta and Pancreatic Cancer

In March of this year, the Food and Drug Administration released the following safety alert: “Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication – Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas.” The FDA reports that it is evaluating academic research that links these drugs with the elevated risk […]

Byetta May Increase Risk of Pancreatic Cancer

A recent study by the Larry L. Hillblom Islet Research Center at the University of California in Los Angeles has found that persons with type 2 diabetes who take Byetta (also known as exenatide) to control their blood-sugar levels may be at greater risk of developing pancreatic cancer. The study uncovered evidence of precancerous changes […]


Your Warriors for Justice
Fight fearlessly. Win strategically.